Treatment Outcomes in Anaplastic Thyroid Cancer

Table 1

Patient characteristics.

	All patients; (N=28)
Age at diagnosis (years)
Median (IQR)	70.9 (63.8 - 74.7)
Sex
Female	16 (57.1%)
Male	12 (42.9%)
Race
Caucasian	22 (78.6%)
African-American	6 (21.4%)
Leukocytosis
No	12 (42.9%)
Yes	12 (42.9%)
Unknown	4 (14.3%)
Initial or concomitant diagnosis of differentiated thyroid cancer (papillary or follicular)
No	22 (78.6%)
Yes	6 (21.4%)
Stage
IVA	2 (7.1%)
IVB	20 (71.4%)
IVC	5 (17.9%)
Unknown	1 (3.6%)
T stage
T2	1 (3.6%)
T3	1 (3.6%)
T4a	13 (46.4%)
T4b	12 (42.9%)
Unknown	1 (3.6%)
N stage
N0	9 (32.1%)
N1a	1 (3.6%)
N1b	4 (14.3%)
Nx or Unknown	14 (50.0%)
M stage
M0	7 (25.0%)
M1	5 (17.9%)
Mx or Unknown	16 (57.1%)
Lymphovascular invasion
No	5 (17.9%)
Yes	14 (50.0%)
Unknown	9 (32.1%)
Extrathyroidal extension
No	4 (14.3%)
Yes	23 (82.1%)
Unknown	1 (3.6%)

Counts and column percentages are presented unless otherwise specified.